


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Recently Viewed
GERN
Geron
SLS
SELLAS Life Sciences
ALB
Albemarle
DRS
Leonardo DRS Inc.
GM
General Motors
Most Trending
+20.45%
+0.49%
-3.49%
+6.50%
+0.14%
GERN
Geron
$1.56
Strengths

Upgraded on attractively valued
GERN Price Performance
$1.61 (-3.11%)
$1.28 (+21.88%)
$1.27 (+22.83%)
$1.75 (-10.86%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
GERN Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GERN Street Sentiment is bullish and have negative views on the near-term outlook
GERN has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Jan 30, 2026
Reiterate
Buy
TD Cowen
SLS
SELLAS Life Sciences
5.41
+2.44%
GTBP
GT Biopharma Inc.
0.46
-2.66%
What is GERN current stock price?
What are GERN stock strengths?
What is GERN Risk Level?
What is GERN market cap and volume?
What is GERN current Stock IQ?
Should I buy GERN stock right now?
Is GERN a Strong Buy right now?
What does a 'Strong Buy' rating mean for GERN?
What does a 'Strong Sell' rating mean for GERN?
What factors influence GERN's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
GERN
Geron
Current Price
$1.56
Runners Also Watch
SLS
SELLAS Life Sciences
5.41
+2.44%
GTBP
GT Biopharma Inc.
0.46
-2.66%

GERN Price Performance
$1.61 (-3.11%)
$1.28 (+21.88%)
$1.27 (+22.83%)
$1.75 (-10.86%)
GERN Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
GERN Analysts opinion is negative and has getting worse from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GERN Street Sentiment is bullish and have negative views on the near-term outlook
GERN has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
GERN Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued
GERN Latest Analysis
Geron: Why Im Doubling Down On My Sell Rating After Q4 Earnings.
Thu Feb 26, 2026
Geron falls as Q4 results miss expectations.
Wed Feb 25, 2026
Geron misses FY earnings result.
Wed Feb 25, 2026
Geron (GERN) Sets 2026 Financial Goals TD Cowen Cuts PT. Geron Corporation (NASDAQ:GERN) is one of the 13 Best American Penny Stocks to Invest In. On January 29 TD Cowen analyst Tara Bancroft reduced the firms price target on Geron Corporation (NASDAQ:GERN) from $4 to $3 and maintained a Buy rating on the stock. This update comes before the companys fourth-quarter results which the company [….]
Mon Feb 23, 2026
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). FOSTER CITY Calif. Feb. 18 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) a commercial stage biopharmaceutical company today reported that effective February 17 2026 it granted stock options to purchase an aggregate of 742500 shares of common stock to one newly hired employee as an inducement material to such employees acceptance of employment with Geron.
Wed Feb 18, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GERN Stock trends
GERN Stock performance
GERN Stock analysis
GERN investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.